Clinical trials are research studies that aim to evaluate the safety and efficacy of new medical treatments and interventions. They play a critical role in advancing medical knowledge and bringing new, effective treatments to patients. It’s important to note that signing up for a clinical trial is easy and only takes a couple of minutes and can sometimes provide compensation to participants. Additionally, at Mindcology, we have a focus on connecting patients with clinical trials related to mental health and the brain, as these are important areas of research that can greatly impact people’s lives.
Here you will find a list of trials currently enrolling. In the trial summary it will tell you what qualifications such as age, diagnosis or general are required to participate. When signing up it only takes a minute and can be a powerful step in changing your life. All information submitted is confidential under HIPPA standards.
This clinical trial is open to individuals 18 years or older who have been diagnosed with PTSD by a doctor. Participants must not have any other neurological disorders or sleep disturbances. Those who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for their time and travel. PTSD is a mental health condition that can occur after experiencing or witnessing a traumatic event. If symptoms persist for more than a few months, it may be diagnosed as PTSD. Patients must be in the US and not all locations are covered.
This study is looking for individuals with Autism Spectrum Disorder (ASD), a developmental disability caused by differences in the brain, between the ages of 15-45. The study is open to individuals of any gender and compensation is available. Patients must be in the US and not all locations are covered.
Relapsing-Remitting Multiple Sclerosis
This clinical trial is open to individuals between the ages of 18 and 60, regardless of gender. Participants may receive compensation for their involvement. The study focuses on individuals diagnosed with relapsing-remitting multiple sclerosis (MS). This form of MS is characterized by alternating periods of stability and relapses, where relapses are defined as episodes of new or worsening symptoms lasting longer than 48 hours and not caused by fever or infection. Relapsing-remitting MS is the most common type of MS and is more prevalent in younger individuals. Patients must be in the US and not all locations are covered.
Parkinson’s is a lifelong, progressive neurodegenerative disorder that affects the brain and leads to worsening symptoms over time. The condition occurs when the brain cells producing dopamine, a neurotransmitter that helps the body function by sending messages between nerve cells or between nerve cells and muscle cells, stop working or die. Dopamine affects both physical and mental function. The hallmark symptoms of Parkinson’s are resting tremor, rigidity, slowness of movement (bradykinesia), and postural instability, which cause unsteadiness and difficulties with balance. These movement-related symptoms are why Parkinson’s is classified as a movement disorder. This study is open to individuals of any gender between the ages of 40-80 and compensation may be provided. Patients must be in the US and not all locations are covered.
This clinical trial is open to individuals between the ages of 18 and 80, regardless of gender. Participants who meet the eligibility criteria may be compensated up to $100 for their time and travel. The study focuses on individuals diagnosed with essential tremor, a neurological disorder causing involuntary rhythmic shaking, often in the hands during simple tasks. To participate, individuals must have a prior medical diagnosis of essential tremor, with moderate to severe interference in daily life, and the diagnosis must be at least 3 years old. They cannot be taking any medications to treat their essential tremor and cannot work from 8 PM to 12 AM. Patients must be in the US and not all locations are covered.